INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, active control trial to determine the safety, efficacy and
pharmacokinetics of INV-144 versus losartan potassium plus placebo in subjects with
hypertension and Type 2 diabetes mellitus with nephropathy as evidenced by albuminuria.